Date published: 2026-3-3

1-800-457-3801

SCBT Portrait Logo
Seach Input

BC002230 Activators

BC002230 activators encompass a diverse set of chemical compounds that amplify the functional activity of BC002230 through distinct signaling pathways. Forskolin, for instance, by raising intracellular cAMP levels, indirectly amplifies BC002230's functional activity by enabling PKA-mediated phosphorylation, a key modification for BC002230 activation. The use of PMA as a PKC activator also contributes to the enhancement of BC002230 by facilitating phosphorylation events that promote BC002230's involvement in cellular proliferation and differentiation pathways. EGCG, through its kinase inhibitory action, allows for the enhanced activity of BC002230 by preventing phosphorylation-mediated inactivation, while sphingosine-1-phosphate boosts BC002230 activity by engaging sphingolipid signaling leading to phosphorylation. Ionomycin's calcium mobilization can further potentiate BC002230 through the activation of calcium-dependent kinases, which underscores the multifaceted nature of BC002230 activation mechanisms.

Once a compound has successfully passed these rigorous initial tests, it undergoes a series of analytical procedures to detail its interaction with BC002230. Structural characterization techniques like X-ray crystallography or nuclear magnetic resonance (NMR) spectroscopy can provide a detailed view of the compound's binding site and reveal the precise nature of its interaction with BC002230. Such structural insights are invaluable as they lay the groundwork for understanding the molecular basis of activation. Alongside these structural studies, biophysical methods such as surface plasmon resonance (SPR) and isothermal titration calorimetry (ITC) offer quantitative data on the binding kinetics and thermodynamics. These data points are critical for elucidating how readily and robustly the activators associate and dissociate from BC002230, which can inform the development of compounds with optimal binding characteristics. In parallel, structure-activity relationship (SAR) studies are conducted to dissect the relationship between the activators' chemical structure and their ability to modulate BC002230.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

PMA

16561-29-8sc-3576
sc-3576A
sc-3576B
sc-3576C
sc-3576D
1 mg
5 mg
10 mg
25 mg
100 mg
$41.00
$132.00
$214.00
$500.00
$948.00
119
(6)

PMA acts as a PKC activator. PKC phosphorylation can enhance the activity of BC002230 by promoting its role in signaling pathways related to cell growth and differentiation.

(−)-Epigallocatechin Gallate

989-51-5sc-200802
sc-200802A
sc-200802B
sc-200802C
sc-200802D
sc-200802E
10 mg
50 mg
100 mg
500 mg
1 g
10 g
$43.00
$73.00
$126.00
$243.00
$530.00
$1259.00
11
(1)

EGCG is a kinase inhibitor that can enhance BC002230 activity by inhibiting kinases that negatively regulate BC002230's pathway, thus preventing deactivation.

D-erythro-Sphingosine-1-phosphate

26993-30-6sc-201383
sc-201383D
sc-201383A
sc-201383B
sc-201383C
1 mg
2 mg
5 mg
10 mg
25 mg
$165.00
$322.00
$570.00
$907.00
$1727.00
7
(1)

Sphingosine-1-phosphate activates sphingosine kinase, which in turn can lead to the phosphorylation and activation of BC002230 through sphingolipid signaling pathways.

Ionomycin

56092-82-1sc-3592
sc-3592A
1 mg
5 mg
$78.00
$270.00
80
(4)

Ionomycin increases intracellular calcium levels, which can activate calcium-dependent protein kinases that phosphorylate and enhance BC002230 activity.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

LY294002 is a PI3K inhibitor that can enhance BC002230 by reducing PI3K/AKT pathway activity, which may otherwise negatively regulate BC002230 through feedback inhibition.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$64.00
$246.00
136
(2)

U0126 is an MEK inhibitor that can indirectly enhance BC002230 by reducing ERK phosphorylation, which might negatively regulate BC002230 through a feedback mechanism.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

SB203580 is a p38 MAPK inhibitor that can enhance BC002230 activity by blocking p38 MAPK-mediated negative regulatory effects on BC002230's function.

Thapsigargin

67526-95-8sc-24017
sc-24017A
1 mg
5 mg
$136.00
$446.00
114
(2)

Thapsigargin raises intracellular calcium levels by inhibiting the SERCA pump, subsequently activating calcium-dependent kinases that can enhance BC002230 activity.

Genistein

446-72-0sc-3515
sc-3515A
sc-3515B
sc-3515C
sc-3515D
sc-3515E
sc-3515F
100 mg
500 mg
1 g
5 g
10 g
25 g
100 g
$45.00
$164.00
$200.00
$402.00
$575.00
$981.00
$2031.00
46
(1)

Genistein is a tyrosine kinase inhibitor that may enhance BC002230 by inhibiting competitive tyrosine kinase signaling, thus allowing BC002230's signaling pathway to be more active.

Staurosporine

62996-74-1sc-3510
sc-3510A
sc-3510B
100 µg
1 mg
5 mg
$82.00
$153.00
$396.00
113
(4)

Staurosporine is a broad-spectrum protein kinase inhibitor that might enhance BC002230 by selectively inhibiting kinases that negatively regulate BC002230's pathways.